Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in PCSK9 Inhibitors
by Most Patent Filings in the world in 2022

The PCSK9 Inhibitors top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filings PCSK9 Inhibitors Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
The PCSK9 inhibitors are a class of injectable drugs approved in 2015 that have been shown to dramatically lower LDL cholesterol levels -- by up to 60% in some cases -- when combined with a statin.. PCSK9 inhibitors are monoclonal antibodies (MABs), a type of biologic drug. They bind to and inactivate an enzyme in the liver called proprotein convertase subtilisin kexin 9 (PCSK9).
#
Company Name
Region
Tech Topics
Total
1
Patent: 188
2
Hovedstaden, Denmark
Insulin,Health care,Haemophilia,
...[+2]
Patent: 28
3
Cambridgeshire, United Kingdom
Medicine,Health care,Side effect,
...[+2]
Patent: 20
4
Cambridgeshire, United Kingdom
Patent: 20
5
Basel-Stadt, Switzerland
Dosage form,Health care,Medicine,
...[+2]
Patent: 16
6
Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER,
...[+2]
Patent: 16
7
Patent: 15
8
Switzerland
Medicine,Health care,Drug,
...[+2]
Patent: 11
9
Guangdong Sheng, China
Patent: 5
10
Île-de-France, France
Health care,Pharmacy and Therapeutics,Drug,
...[+2]
Patent: 4
11
Medicine,Health care,Drug class,
...[+2]
Patent: 3
12
Ontario, Canada
Patent: 3
13
Dogma Therapeutics, Inc.
PCSK9,Cardiovascular agent,Biophysics,
...[+2]
Patent: 3
14
United Kingdom
Patent: 3
15
IF, FR
Patent: 3
16
Patent: 3
17
Health care,Biopharmaceutical,Drug,
...[+2]
Patent: 2
18
Pokka Corp.
Aichi, Japan
Food industry,Soft drink,Fountain,
...[+1]
Patent: 2
19
Patent: 2
20
Patent: 2
Page generation time: May 16 2025